Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's disease

被引:45
作者
Lou, JS
Benice, T
Kearns, G
Sexton, G
Nutt, J
机构
[1] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[2] Oregon Hlth Sci Univ, Clin Res Ctr, Portland, OR 97201 USA
关键词
Parkinson's disease; transcranial magnetic stimulation; levodopa; physical fatigue; post-exercise facilitation; cortico-motoneuron excitability;
D O I
10.1016/S1388-2457(03)00040-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To measure exercise induced changes in cortico-motoneuron excitability in Parkinson's disease (PD) before and after levodopa. Methods: Transcranial magnetic stimulation was delivered at 10% above resting motor threshold in 9 PD and 8 control subjects. Each subject performed repetitive isometric wrist extension at 50% of the baseline maximal voluntary contraction (MVC) for 30 s with 3 s rest between extensions until fatigued, defined as the inability to generate force at more than 25% of the baseline MVC. We recorded motor evoked potentials (MEPs) from the resting extensor carpi radialis muscle before (baseline), during, and after fatiguing exercise. Baseline electromyographic activity was closely monitored. We compared absolute MEP amplitudes between PD and controls, before and after levodopa, during baseline, exercise, and recovery periods. We correlated absolute MEP amplitudes with an objective measure of fatigability. Results: PD subjects in the "off" state had increased absolute MEP amplitudes compared with controls. The effect was present in all 3 exercise periods. These differences disappeared after levodopa. Post-exercise facilitation was clear for PD subjects before and after levodopa, but post-exercise depression was not significant. Absolute MEP amplitude showed negative correlation with objective fatigability for PD subjects before levodopa. Conclusions: Levodopa normalized the increased cortico-motoneuron excitability in PD patients before, during, and after fatiguing exercise. Significance: This study demonstrated the abnormal cortico-motoneuron excitability associated with motor fatigue in PD. (C) 2003 International Federation of Clinical Neurophysiology. Published by Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:930 / 937
页数:8
相关论文
共 20 条
[11]   Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa [J].
Haslinger, B ;
Erhard, P ;
Kämpfe, N ;
Boecker, H ;
Rummeny, E ;
Schwaiger, M ;
Conrad, B ;
Ceballos-Baumann, AO .
BRAIN, 2001, 124 :558-570
[12]  
INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521
[13]   Exacerbated physical fatigue and mental fatigue in Parkinson's disease [J].
Lou, JS ;
Kearns, G ;
Oken, B ;
Sexton, G ;
Nutt, J .
MOVEMENT DISORDERS, 2001, 16 (02) :190-196
[14]   MOTOR CORTICAL INHIBITION AND THE DOPAMINERGIC SYSTEM - PHARMACOLOGICAL CHANGES IN THE SILENT PERIOD AFTER TRANSCRANIAL BRAIN-STIMULATION IN NORMAL SUBJECTS, PATIENTS WITH PARKINSONS-DISEASE AND DRUG-INDUCED PARKINSONISM [J].
PRIORI, A ;
BERARDELLI, A ;
INGHILLERI, M ;
ACCORNERO, N ;
MANFREDI, M .
BRAIN, 1994, 117 :317-323
[15]   CHANGES IN EXCITABILITY OF MOTOR CORTICAL CIRCUITRY IN PATIENTS WITH PARKINSONS-DISEASE [J].
RIDDING, MC ;
INZELBERG, R ;
ROTHWELL, JC .
ANNALS OF NEUROLOGY, 1995, 37 (02) :181-188
[16]   Characterization of postexercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation [J].
Samii, A ;
Wassermann, EM ;
Ikoma, K ;
Mercuri, B ;
Hallett, M .
NEUROLOGY, 1996, 46 (05) :1376-1382
[17]   Changes in motor cortical excitability during human muscle fatigue [J].
Taylor, JL ;
Butler, JE ;
Allen, GM ;
Gandevia, SC .
JOURNAL OF PHYSIOLOGY-LONDON, 1996, 490 (02) :519-528
[18]   ABNORMAL FACILITATION OF THE RESPONSE TO TRANSCRANIAL MAGNETIC STIMULATION IN PATIENTS WITH PARKINSONS-DISEASE [J].
VALLSSOLE, J ;
PASCUALLEONE, A ;
BRASILNETO, JP ;
CAMMAROTA, A ;
MCSHANE, L ;
HALLETT, M .
NEUROLOGY, 1994, 44 (04) :735-741
[19]  
ZIEMANN U, 1997, ELECTROEN CLIN NEURO, V105, P30
[20]   Enhanced fatigue during motor performance in patients with Parkinson's disease [J].
Ziv, I ;
Avraham, M ;
Michaelov, Y ;
Djaldetti, R ;
Dressler, R ;
Zoldan, J ;
Melamed, E .
NEUROLOGY, 1998, 51 (06) :1583-1586